Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jan 15, 2020; 12(1): 113-123
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.113
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.113
Figure 4 Meta-analysis of six studies after excluding all studies which found a statistically significant survival advantage in the experimental group.
HR: hazard ratio; N(T): Number of patients in the experimental group; N(C): Number of patients in the control group; W(fixed): Weight assigned to the study by using a fixed-effect model; W(random): Weight assigned to the study by using a random-effect model.
- Citation: Manzini G, Klotz U, Henne-Bruns D, Kremer M. Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials. World J Gastrointest Oncol 2020; 12(1): 113-123
- URL: https://www.wjgnet.com/1948-5204/full/v12/i1/113.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i1.113